Michael J. Tokich, a director at Mettler Toledo International Inc., has reported recent transactions involving the company's stock. This filing is significant as it underscores Tokich's active role in the company's equity management.
Background
Mettler Toledo International Inc. operates in the laboratory analytical instruments sector, classified under the SIC code 3826. The company is publicly traded under the ticker symbol MTD. Its headquarters is located in Columbus, Ohio, and it is incorporated in Delaware.
What the Filing Says
In the filing dated November 12, 2026, Tokich disclosed that on November 10, 2026, he acquired 54 shares of Mettler Toledo's common stock, bringing his total ownership to 104 shares. Additionally, he reported the acquisition of 130 stock options, which have an exercise price of $1,751.38.
Impact
This update may affect shareholders and potential investors by providing insights into Tokich's confidence in the company's future. As a director, his stock transactions could influence perceptions of Mettler Toledo's governance and strategic direction.
What's Next
The filing does not say what happens next.
Details of the Transactions
Tokich's acquisition of 54 shares on November 10, 2026, was executed at a transaction price of $0 per share, indicating that the shares were likely obtained through an employee stock purchase plan or similar arrangement. Following this transaction, Tokich's total ownership increased to 104 shares of Mettler Toledo's common stock.
In addition to the common stock acquisition, Tokich also reported the acquisition of 130 stock options, which have an exercise price of $1,751.38. These options are set to expire on November 10, 2036, and will vest annually in two equal installments starting on the first anniversary of the grant date, which suggests a long-term commitment to the company's performance.
Ownership Structure
As a director, Tokich holds direct ownership of both the common shares and stock options, reflecting a personal investment in the company’s success. The filing indicates that he is not an officer or a ten-percent owner, positioning him as a key influencer in the company's governance without holding executive power.
Additional Information
The filing does not provide information on the context of these transactions, such as whether they were part of a broader strategy or market conditions at the time. There is also no mention of any other recent transactions by Tokich or other directors that might provide additional insight into the company's direction.
Read Next
Obsidian Therapeutics reports ownership change for Reisenauer
V-Cube, Inc. Reports Significant Ownership in TEN Holdings
enGene Therapeutics files Form 3, disclosing no ownership
Kris Corbett Files Form 3 as CFO of Audax Credit BDC Inc.
Abbate Salvatore A Files Form 3 as CEO of LKQ Corp
Angi Inc. Files Form 3 Reporting Officer Change










